secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001193125-24-161587
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Disc Medicine prices $178M underwritten offering of 4.94M shares at $36.00
--------------------------------------------------------------------------

- Priced 4,944,000 shares at $36.00; gross proceeds ~$178M, net ~$172.3M.
- Offering led by Frazier Life Sciences and Logos Capital with other institutional investors.
- Net proceeds to fund clinical development, R&D, and working capital; cash runway extended into 2027.
- Expected to close June 17, 2024; Leerink Partners acts as sole bookrunner.
- Offered under effective shelf registration statement (Form S-3, No. 333-275652).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000119312524161587/0001193125-24-161587-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000119312524161587/d828009d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-161587

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer